Efficacy and safety of PARP inhibitors in patients with BRCA-mutated advanced breast cancer: A meta-analysis and systematic review

Objective: This meta-analysis aimed to investigate the efficacy and safety of poly (adenosine diphosphate-ribose) polymerase (PARP) inhibitors in BRCA-mutated advanced breast cancer patients comprehensively. Methods: We conducted a systematic literature research through PubMed, the Cochrane Central...

Full description

Bibliographic Details
Main Authors: Ximu Sun, Xin Wang, Jie Zhang, Zhixia Zhao, Xin Feng, Lihong Liu, Zhuo Ma
Format: Article
Language:English
Published: Elsevier 2021-12-01
Series:Breast
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977621004392